[¹⁸F]FDG

Clinical Evaluation	Glucose metabolism
Type of Imaging	PET
Grade of Recommendation	A (strongly recommended)
Level of Evidence	well-established clinical and Nuclear Medicine recommendations
Effective Dose	19.0 µSv/MBq
Bibliographic Reference	A. Cervantes, R. Adam, S. Roselló, et al, on behalf of the ESMO Guidelines Committee. Metastatic colorectal cancer: ESMO Clinical Practice Guideline f... read more A. Cervantes, R. Adam, S. Roselló, et al, on behalf of the ESMO Guidelines Committee. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023 NCCN GL v3.2021, https://www.nccn.org/guidelines/nccn-guidelines Lambie H, Cook AM, Scarsbrook AF, Lodge JP, Robinson PJ, Chowdhury FU. Tc99m-hepatobiliary iminodiacetic acid (HIDA) scintigraphy in clinical practice. Clin Radiol. 2011; https://doi.org/10.1016/j.crad.2011.07.045. read less
Guide to Nuclear Medicine	Read the corresponding chapter

Clinical Evaluation
Glucose metabolism
Type of Imaging
PET
Grade of Recommendation
A (strongly recommended)
Level of Evidence
well-established clinical and Nuclear Medicine recommendations
Effective Dose
19.0 µSv/MBq
Bibliographic Reference
A. Cervantes, R. Adam, S. Roselló, et al, on behalf of the ESMO Guidelines Committee. Metastatic colorectal cancer: ESMO Clinical Practice Guideline f... read more A. Cervantes, R. Adam, S. Roselló, et al, on behalf of the ESMO Guidelines Committee. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023 NCCN GL v3.2021, https://www.nccn.org/guidelines/nccn-guidelines Lambie H, Cook AM, Scarsbrook AF, Lodge JP, Robinson PJ, Chowdhury FU. Tc99m-hepatobiliary iminodiacetic acid (HIDA) scintigraphy in clinical practice. Clin Radiol. 2011; https://doi.org/10.1016/j.crad.2011.07.045. read less
Guide to Nuclear Medicine
Read the corresponding chapter

[18F]FDG